The Clinical Research Coordinating Office (CRCO) serves UW Carbone Cancer Center (UWCCC) members and researchers by providing administrative infrastructure and oversight of all clinical and translational research conducted at the UWCCC, with the principal goal to ensure scientifically sound and high quality clinical research across the UWCCC. The CRCO is composed of experienced research staff that provides support for the strategic aspects of identifying, prioritizing and conducting clinical research activities at UWCCC and UW Affiliate Site Network (Wisconsin Oncology Network). These functions are accomplished through its interactions with key research entities (IRB, Pharmaceutical Research Center and Disease Oriented Working Groups/Clinical Research Groups) and the clinical care entities (Clinical Research Unit, UW Hospital and Clinics). The CRCO also provides essential administrative support to UWCCC clinical research committees such as the Protocol Review and Monitoring Committee and Data Safety and Monitoring Committee. The CRCO staff members provide the following services;? Protocol review and implementation, which includes protocol identification, protocol review, protocol activation, study closure, and database management ? Human subjects committee coordination and oversight, which includes protocol activation and continuing annual review tracking ? Centralized patient tracking ? Research policy development, coordination and implementation, which is developed and implemented through the Program Manager Committee and the development of standard operating procedures ? Training coordination and implementation ? Education and corrective action facilitation ? Administrative oversight ? Protocol development and patient case report forms development for Investigator Initiated Trials ? Data abstraction and final report tables for Investigator Initiated Trials The Faculty Leader for the CRCO is the Associate Director for Clinical Research (Brad Kahl, M.D.), who has extensive experience in the conduct and oversight of clinical research.

Public Health Relevance

The Clinical Research Coordinating Office (CRCO) serves UW Carbone Cancer Center (UWCCC) members and researchers by providing administrative infrastructure and oversight of all clinical and translational research conducted at the UWCCC, with the principal goal to ensure scientifically sound and high quality clinical research across the UWCCC. The CRCO is composed of experienced research staff that provides support for the strategic aspects of identifying, prioritizing and conducting clinical research activities at UWCCC and UW Affiliate Site Network (Wisconsin Oncology Network).

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA014520-39
Application #
8483761
Study Section
Subcommittee G - Education (NCI)
Project Start
1997-04-25
Project End
2018-03-31
Budget Start
2013-04-12
Budget End
2014-03-31
Support Year
39
Fiscal Year
2013
Total Cost
$187,336
Indirect Cost
$66,047
Name
University of Wisconsin Madison
Department
Type
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Goel, Shreya; Ferreira, Carolina A; Chen, Feng et al. (2018) Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy. Adv Mater 30:
Wei, Weijun; Ehlerding, Emily B; Lan, Xiaoli et al. (2018) PET and SPECT imaging of melanoma: the state of the art. Eur J Nucl Med Mol Imaging 45:132-150
Yu, Bo; Wei, Hao; He, Qianjun et al. (2018) Efficient Uptake of 177 Lu-Porphyrin-PEG Nanocomplexes by Tumor Mitochondria for Multimodal-Imaging-Guided Combination Therapy. Angew Chem Int Ed Engl 57:218-222
Ehlerding, Emily B; Lacognata, Saige; Jiang, Dawei et al. (2018) Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody. Eur J Nucl Med Mol Imaging 45:123-131
Shea, Michael P; O'Leary, Kathleen A; Wegner, Kyle A et al. (2018) High collagen density augments mTOR-dependent cancer stem cells in ER?+ mammary carcinomas, and increases mTOR-independent lung metastases. Cancer Lett 433:1-9
Conklin, Matthew W; Gangnon, Ronald E; Sprague, Brian L et al. (2018) Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ. Cancer Epidemiol Biomarkers Prev 27:138-145
Ko, Huaising C; Kimple, Randall J (2018) The Resident Individual Development Plan as a Guide for Radiation Oncology Mentorship. Int J Radiat Oncol Biol Phys 101:786-788
McDermott, Andrew J; Tumey, Tyler A; Huang, Mingwei et al. (2018) Inhaled Cryptococcus neoformans elicits allergic airway inflammation independent of Nuclear Factor Kappa B signalling in lung epithelial cells. Immunology 153:513-522
You, Xiaona; Kong, Guangyao; Ranheim, Erik A et al. (2018) Unique dependence on Sos1 in Kras G12D -induced leukemogenesis. Blood 132:2575-2579
Ferreira, Carolina A; Hernandez, Reinier; Yang, Yunan et al. (2018) ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model. Mol Pharm 15:3434-3441

Showing the most recent 10 out of 1528 publications